Havana Cuba Business Travel Culture and Politics

Havana Cuba News

Cuba Culture News

Posted June 11, 2006 by publisher in Cuban Healthcare

Email this article | Print this article | Search Havana Journal        


The first ever monoclonal antibody obtained starting from transgenic plants with the purpose of purifying a human vaccine was registered in Cuba by the State Center for the Control of Medication Quality (CECMED), the regulating authority in charge of the control of medical drugs of the Ministry of Public Health.

This is the first ever monoclonal antibody registered in the world for this purpose and coming from genetically modified plants, according to Dr. Carlos Borroto, the deputy director of Havana�s Genetic Engineering and Biotechnology Center (CIGB).

Monoclonal antibodies are laboratory substances that are joined to specific cells, and each one only recognizes a protein or antigen as its target, explains a report on Granma daily newspaper.

The antibody is used in the process of purifying the active pharmaceutical ingredient of the Hepatitis B vaccine produced in Cuba by the CIGB sold under the trade mark of Heberbiovac-HB.

In comparison with the traditional production process, starting from the ascitic liquid of the mouse, obtaining the antibody from genetically modified tobacco plants, has advantages due to higher levels of safety and industrial possibilities, said Doctor Borroto.

Borroto made it clear that the tobacco plantations that were genetically modified have nothing to do with the commercial strains of that plant that are cultivated in Cuba.

He noted that the CIGB has taken appropriate actions to avoid possible risks to the environment when cultivating transgenic strains. This production process is confined to special controlled growing areas, where the technology specifically created with that purpose is in use, according to the Good Agricultural Production Practices demanded in the obtaining of vegetable biomass for pharmaceutical applications, Dr. Borroto confirmed.

This monoclonal antibody obtained from transgenic plants obtained the license granted by the National Center of Biological Safety that is part of the Cuban Ministry of Science, Technology and the Environment.

Approval by CECMED guarantees that the monoclonal antibody obtained as well as the innovative process that precedes it, has quality standards that are equivalent to the one obtained from the mouse ascitic liquid according to the existing international standards for the pharmaceutical industry.

Find Cuba biotechnology on Amazon

  1. Follow up post #1 added on January 15, 2011 by neamat tayebi

    hi dear
    Im from iran and i study Ms plant physiology at shiraz university and i want study Ph.d in field of biopharmcy in good university of world.
    plaese guide and help me.

Would you like to add more information?

Only members can add more information. Please register or log in

  • Advertise at Havana Journal Inc
We recommend this AirBnB Food and Drink Experience... Cuban flavors: Food, Rum and Cigars
Images of Cuba
Regreso cigars
Follow Havana Journal
SUBSCRIBE to our Cuba Watch newsletter
LIKE us on Facebook

FOLLOW us on Twitter

CONNECT with us on Linked In

Section Archive
Havana Journal, Inc. BBB Business Review

Member of the Association for the Study of the Cuban Economy